MR [Mindray Medical International] UPLOAD:
[]
JD [JD.com] 6-K: (Original Filing)
[JD.com Announces Fourth Quarter and Full Year 2015 Results Beijing, China Fourth Quarter and Full Year 2015 Highlights 1 · GMV GMV 2 · Net revenues services and others Net revenues services and others · Net loss attributable to ordinary shareholders Non-GAAP net loss attributable to ordinary shareholders 3 non-GAAP net margin Non-GAAP net loss attributable to ordinary shareholders non-GAAP] [001-36450 JD.com, Inc. 20th Floor, Building A, No. 18 Kechuang 11 Street Yizhuang Economic and Technological Development Zone Form 20-F x o o o JD.COM, INC. By :]
JD [JD.com] 6-K: JD.com Announces Fourth Quarter and Full Year 2015
[JD.com Announces Fourth Quarter and Full Year 2015 Results Beijing, China Fourth Quarter and Full Year 2015 Highlights 1 · GMV GMV 2 · Net revenues services and others Net revenues services and others · Net loss attributable to ordinary shareholders Non-GAAP net loss attributable to ordinary shareholders 3 non-GAAP net margin Non-GAAP net loss attributable to ordinary shareholders non-GAAP] [001-36450 JD.com, Inc. 20th Floor, Building A, No. 18 Kechuang 11 Street Yizhuang Economic and Technological Development Zone Form 20-F x o o o JD.COM, INC. By :]
CBPO [China Biologic Products] FWP: (Original Filing)
[Issuer Free Writing Prospectus dated March 2, 2016 Relating to Preliminary Prospectus Supplements dated March 1, 2016 to Prospectus dated June 5, 2015 Registration No. 333-204761 Unless the context requires otherwise, the words “we” and “our” refer to China Biologic Products, Inc. The following information updates the information contained in our preliminary prospectus supplement dated March 1, 2016. In the]
CBPO [China Biologic Products] FWP: Issuer Free Writing Prospectus dated March 2, 2016
[Issuer Free Writing Prospectus dated March 2, 2016 Relating to Preliminary Prospectus Supplements dated March 1, 2016 to Prospectus dated June 5, 2015 Registration No. 333-204761 Unless the context requires otherwise, the words “we” and “our” refer to China Biologic Products, Inc. The following information updates the information contained in our preliminary prospectus supplement dated March 1, 2016. In the]
GRO [AGRIA] 6-K: (Original Filing)
[Agria Reports Financial Results for First Half of Fiscal Year 2016 Significant Impacts From Strength of US Dollar, Unusual Weather; On “Constant Currency” Basis, Revenue Down 5%, Net Income Down 61% HONG KONG, CHINA -- (Marketwired - March 1, 2016) - Agria Corporation (NYSE: GRO) (the "Company" or "Agria"), a global agricultural company, today announced its financial results for the] []
GRO [AGRIA] 6-K: Agria Reports Financial Results for First Half of
[Agria Reports Financial Results for First Half of Fiscal Year 2016 Significant Impacts From Strength of US Dollar, Unusual Weather; On “Constant Currency” Basis, Revenue Down 5%, Net Income Down 61% HONG KONG, CHINA -- (Marketwired - March 1, 2016) - Agria Corporation (NYSE: GRO) (the "Company" or "Agria"), a global agricultural company, today announced its financial results for the] []
